ATE398607T1 - Pyrazolderivate und deren verwendung als therapeutische mittel für durch hiv vermittelte krankheiten - Google Patents

Pyrazolderivate und deren verwendung als therapeutische mittel für durch hiv vermittelte krankheiten

Info

Publication number
ATE398607T1
ATE398607T1 AT03799023T AT03799023T ATE398607T1 AT E398607 T1 ATE398607 T1 AT E398607T1 AT 03799023 T AT03799023 T AT 03799023T AT 03799023 T AT03799023 T AT 03799023T AT E398607 T1 ATE398607 T1 AT E398607T1
Authority
AT
Austria
Prior art keywords
hiv
pyrazole derivatives
therapeutic agents
mediated diseases
compounds
Prior art date
Application number
AT03799023T
Other languages
English (en)
Inventor
Paul Edwards
Lyn JONES
Charles MOWBRAY
Paul STUPPLE
Isabelle Tran
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of ATE398607T1 publication Critical patent/ATE398607T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18—One oxygen or sulfur atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT03799023T 2002-10-07 2003-09-24 Pyrazolderivate und deren verwendung als therapeutische mittel für durch hiv vermittelte krankheiten ATE398607T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0223234.6A GB0223234D0 (en) 2002-10-07 2002-10-07 Chemical compounds

Publications (1)

Publication Number Publication Date
ATE398607T1 true ATE398607T1 (de) 2008-07-15

Family

ID=9945429

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03799023T ATE398607T1 (de) 2002-10-07 2003-09-24 Pyrazolderivate und deren verwendung als therapeutische mittel für durch hiv vermittelte krankheiten

Country Status (11)

Country Link
EP (1) EP1556359B1 (de)
JP (1) JP2006504713A (de)
AT (1) ATE398607T1 (de)
AU (1) AU2003264940A1 (de)
BR (1) BR0314930A (de)
CA (1) CA2501541A1 (de)
DE (1) DE60321700D1 (de)
ES (1) ES2305563T3 (de)
GB (1) GB0223234D0 (de)
MX (1) MXPA05003641A (de)
WO (1) WO2004031156A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2451676C2 (ru) 2006-08-16 2012-05-27 Ф.Хоффманн-Ля Рош Аг Ненуклеозидные ингибиторы обратной транскриптазы
WO2009080534A1 (en) 2007-12-21 2009-07-02 F. Hoffmann-La Roche Ag Heterocyclic antiviral compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0016787D0 (en) * 2000-07-07 2000-08-30 Pfizer Ltd Compounds useful in therapy
GB0024795D0 (en) * 2000-10-10 2000-11-22 Hoffmann La Roche Pyrazole derivatives for the treatment of viral diseases
IL157875A0 (en) * 2001-04-10 2004-03-28 Pfizer Pyrazole derivatives for treating hiv

Also Published As

Publication number Publication date
WO2004031156A1 (en) 2004-04-15
MXPA05003641A (es) 2005-06-08
CA2501541A1 (en) 2004-04-15
EP1556359B1 (de) 2008-06-18
JP2006504713A (ja) 2006-02-09
EP1556359A1 (de) 2005-07-27
AU2003264940A1 (en) 2004-04-23
BR0314930A (pt) 2005-08-02
DE60321700D1 (de) 2008-07-31
ES2305563T3 (es) 2008-11-01
GB0223234D0 (en) 2002-11-13

Similar Documents

Publication Publication Date Title
MY146669A (en) Pyrazole derivatives for treating hiv
NO20055421L (no) Kinolinderivater som fosfodiestrase-inhibitorer
TR200302242T2 (tr) Protein kinaz önleyicileri olarak pirolopirimidinler
NO20060981L (no) Pyridazinderivater og deres anvendelse som terapeutiske midler
NO20070224L (no) 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav
MEP43008A (en) Indole-2-carboxamides as factor xa inhibitors
NO20063761L (no) Sulfonamidderivater for behandling av sykdommer
NO20050851L (no) Kaspase-inhibitorer og anvendelser derav
BRPI0413469A (pt) derivados de piperazina para o tratamento de infecções por hiv
ATE475659T1 (de) Neue indolderivate als faktor xa-inhibitoren
ATE527261T1 (de) 7-aryl-3,9-diazabicycloä3.3.1ünon-6-en-derivate und ihre verwendung als renin-inhibitoren zur behandlung von bluthochdruck, herz-kreislauf- erkrankungen und nierenkrankheiten
NO20062983L (no) Sulfonamid-derivater for behandling av sykdommer
ATE384714T1 (de) Pyrazolderivate
NO20050573L (no) 4-'7-halo-2-quino (XA) linyloksy ! fenoksypropionsyrederivater som antineoplastiske midler
BR0314759A (pt) Derivados de pirazol
ATE398607T1 (de) Pyrazolderivate und deren verwendung als therapeutische mittel für durch hiv vermittelte krankheiten
BR0314709A (pt) Derivados de pirazol
HUP0203161A2 (hu) Benzamidinszármazékok, eljárás az előállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
AP1846A (en) Pyrazole Derivatives.
DK1501823T3 (da) Hidtil ukendte piperidinyl-alkylamino-pyridazinon-derivater, en fremgangsmåde til fremstilling deraf og farmaceutiske præparater der indeholder forbindelserne
NO20064805L (no) Sammensetninger for behandling av sykdommer
TNSN03088A1 (fr) Derives de pyrazole pour le traitement d'une infection par le vih
HRP20060456A2 (hr) Inhibitori 11-beta-hidroksisteroid-dehidrogenaze tipa 1
NO20063875L (no) Forbindelser som anvendes for behandling av sykdommer

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties